Ikmat A. Adesanya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ikmat A. Adesanya has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Aaron T. Winder
Charles River Analytics, Cambridge, MA 02138, USA
1 shared publication - Amber S. Kleckner
Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, USA
1 shared publication - Carin L. Clingan
Department of Pain and Translational Symptom Science, School of Nursing (UMSON), University of Maryland, Baltimore, USA
1 shared publication - Dana Deighton
Melanoma Research Alliance, Washington, DC
1 shared publication Deborah Taber
School of Nursing University of Maryland Baltimore Baltimore Maryland USA
1 shared publication- Emily Werthman
Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine , Baltimore, MD 21287
1 shared publication
Latest Publications
- 27 November 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (5) , 2418-2430
Leveraging technology to address POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC): A phase I/II randomized controlled trial of a survivorship care plan mobile application
Background Survivorship Care Plans (SCPs) support the transition from active cancer treatment to long-term survivorship. The POSTHOC mobile application (app) was developed to digitize the SCP, improving accessibility, modifiability, longevity, and usefulness, while promoting adherence to diet and physical activity recommendations. This study tested the feasibility, acceptability, and usability of the POSTHOC app and its effect on global symptom burden compared to a traditional SCP among recent cancer survivors. Methods In a phase I/II randomized controlled trial, cancer survivors within 12 weeks of curative treatment were recruited. Participants were randomized 2:1 POSTHOC:usual care. The POSTHOC arm had full use of the app for 12 weeks, while the usual care arm received a static SCP. Outcomes were assessed at baseline, 6 weeks, and 12 weeks, which included symptom burden (MD Anderson Symptom Inventory), diet (ASA24, 24-h recall), and physical activity (Fitbit). Acceptability (custom usefulness scale) and usability (System Usability Scale, range 0–100) were assessed within the POSTHOC arm at weeks 6 and 12. Mixed models tested SCP effects on outcomes. At week 12, participants also reflected on patient-provider communication regarding healthy lifestyle behaviors. Results Fifty-one participants consented, 41 participants (80%) successfully downloaded the app, and 34 were randomized. In the POSTHOC group, 48% (95% CI: 28–68%) and 52% (95% CI: 32–72%) recorded symptoms and/or diet in the app at weeks 6 and 12, respectively, which was below the a priori 75% usage hypothesis. POSTHOC participants reported moderate usefulness of the app at week 6 (mean ± SD = 3.5 ± 2.2) and week 12 (4.3 ± 2.4). In regard to usability, POSTHOC participants rated the app 62.7 ± 21.1 at week 6 and 65.7 ± 18.1 at week 12, which is slightly below “average” in industry standards. In regard to exploratory symptom outcomes, the POSTHOC group showed a greater reduction in symptom burden than controls at week 12 [b = 3.40 (95% CI: 0.51‒6.28), p = 0.022, ES = 0.36]. Improvements were also observed at week 12 for memory problems [b = 0.42 (95% CI: 0.03‒0.82), p = 0.034; ES = 0.30] and symptom interference with walking [b = 0.47 (95% CI: 0.05‒0.90), p = 0.030; ES = 0.45]. On average, participants desired more communication about healthy behaviors, reporting dissatisfaction with these conversations on average [2.6 (95% CI 1.5‒3.8), range 1–5]. Conclusions POSTHOC is a partially feasible digital SCP with moderate usability and potential to reduce symptom burden in cancer survivors, supporting mobile health approaches to survivorship care. Future studies should explore the effects of a mobile SCP on symptom outcomes as a primary outcome. Trial Registration ClinicalTrials.gov: NCT05499663. Graphical Abstract
- 27 November 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (5) , 2418-2430
Leveraging technology to address POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC): A phase I/II randomized controlled trial of a survivorship care plan mobile application
Background Survivorship Care Plans (SCPs) support the transition from active cancer treatment to long-term survivorship. The POSTHOC mobile application (app) was developed to digitize the SCP, improving accessibility, modifiability, longevity, and usefulness, while promoting adherence to diet and physical activity recommendations. This study tested the feasibility, acceptability, and usability of the POSTHOC app and its effect on global symptom burden compared to a traditional SCP among recent cancer survivors. Methods In a phase I/II randomized controlled trial, cancer survivors within 12 weeks of curative treatment were recruited. Participants were randomized 2:1 POSTHOC:usual care. The POSTHOC arm had full use of the app for 12 weeks, while the usual care arm received a static SCP. Outcomes were assessed at baseline, 6 weeks, and 12 weeks, which included symptom burden (MD Anderson Symptom Inventory), diet (ASA24, 24-h recall), and physical activity (Fitbit). Acceptability (custom usefulness scale) and usability (System Usability Scale, range 0–100) were assessed within the POSTHOC arm at weeks 6 and 12. Mixed models tested SCP effects on outcomes. At week 12, participants also reflected on patient-provider communication regarding healthy lifestyle behaviors. Results Fifty-one participants consented, 41 participants (80%) successfully downloaded the app, and 34 were randomized. In the POSTHOC group, 48% (95% CI: 28–68%) and 52% (95% CI: 32–72%) recorded symptoms and/or diet in the app at weeks 6 and 12, respectively, which was below the a priori 75% usage hypothesis. POSTHOC participants reported moderate usefulness of the app at week 6 (mean ± SD = 3.5 ± 2.2) and week 12 (4.3 ± 2.4). In regard to usability, POSTHOC participants rated the app 62.7 ± 21.1 at week 6 and 65.7 ± 18.1 at week 12, which is slightly below “average” in industry standards. In regard to exploratory symptom outcomes, the POSTHOC group showed a greater reduction in symptom burden than controls at week 12 [b = 3.40 (95% CI: 0.51‒6.28), p = 0.022, ES = 0.36]. Improvements were also observed at week 12 for memory problems [b = 0.42 (95% CI: 0.03‒0.82), p = 0.034; ES = 0.30] and symptom interference with walking [b = 0.47 (95% CI: 0.05‒0.90), p = 0.030; ES = 0.45]. On average, participants desired more communication about healthy behaviors, reporting dissatisfaction with these conversations on average [2.6 (95% CI 1.5‒3.8), range 1–5]. Conclusions POSTHOC is a partially feasible digital SCP with moderate usability and potential to reduce symptom burden in cancer survivors, supporting mobile health approaches to survivorship care. Future studies should explore the effects of a mobile SCP on symptom outcomes as a primary outcome. Trial Registration ClinicalTrials.gov: NCT05499663. Graphical Abstract
- 7 November 2022
- Published by Wiley in Journal of Advanced Nursing
- Vol. 79 (5) , 1949-1958
Nurse‐led hospital‐to‐community care, clinical outcomes for people living with HIV and health‐related social needs
Aims: To evaluate whether patients with HIV enrolled in Linkage to Care (hospital‐based only) or Linkage to Care Plus (nurse‐led hospital‐to‐community transitional care) programmes fare better on clinical outcomes; and to investigate how factors such as substance use, mental health or health‐related social needs contribute to these outcomes.Background: Social determinants of health contribute to poor HIV outcomes such that only 57% of people living with HIV have achieved the goal of viral suppression nationally, and 50% are retained in clinical care. The programmes evaluated here aimed to increase HIV appointment attendance, retention in care, viral suppression and decrease acute care utilization and mitigate social needs via hospital‐to‐community transitional support.Design: A retrospective observational cohort study.Methods: We conducted a retrospective patient chart review abstracting data over three time periods between 2017 and 2020 to conduct this longitudinal programme evaluation.Results: Both programmes had meaningful effects on increasing HIV appointment attendance and viral suppression; Linkage to Care Plus experienced the largest gains. Older age was associated with viral suppression, and housing insecurity and mental health conditions were associated with increased emergency department utilization.Conclusion: Hospital‐only and nurse‐led hospital‐to‐community transitional care programmes can positively influence HIV care outcomes. There is a need for enhanced attention and accountability related to health‐related social needs, especially housing, and mental and behavioural health, to end the HIV epidemic.Impact: Globally, we are striving to end the HIV epidemic with evidence‐informed interventions. The nurse‐led hospital‐to‐community and the hospital‐only interventions evaluated here improved HIV outcomes with most gains realized by the nurse‐led transitional care model. Integrating lessons from these programmes, with increased attention and accountability for addressing social needs, can improve practice and policies to achieve programmatic and national goals related to HIV and other diseases, and more critically, to meet the goals of the people we serve.Patient or public contribution: Patients, staff and leadership at the University of Maryland Institute of Human Virology JACQUES Initiative and University of Maryland Medical Center THRIVE clinic contributed to the design and implementation of the programmes and informed the programme evaluation study.
- 7 November 2022
- Published by Wiley in Journal of Advanced Nursing
- Vol. 79 (5) , 1949-1958
Nurse‐led hospital‐to‐community care, clinical outcomes for people living with HIV and health‐related social needs
Aims: To evaluate whether patients with HIV enrolled in Linkage to Care (hospital‐based only) or Linkage to Care Plus (nurse‐led hospital‐to‐community transitional care) programmes fare better on clinical outcomes; and to investigate how factors such as substance use, mental health or health‐related social needs contribute to these outcomes.Background: Social determinants of health contribute to poor HIV outcomes such that only 57% of people living with HIV have achieved the goal of viral suppression nationally, and 50% are retained in clinical care. The programmes evaluated here aimed to increase HIV appointment attendance, retention in care, viral suppression and decrease acute care utilization and mitigate social needs via hospital‐to‐community transitional support.Design: A retrospective observational cohort study.Methods: We conducted a retrospective patient chart review abstracting data over three time periods between 2017 and 2020 to conduct this longitudinal programme evaluation.Results: Both programmes had meaningful effects on increasing HIV appointment attendance and viral suppression; Linkage to Care Plus experienced the largest gains. Older age was associated with viral suppression, and housing insecurity and mental health conditions were associated with increased emergency department utilization.Conclusion: Hospital‐only and nurse‐led hospital‐to‐community transitional care programmes can positively influence HIV care outcomes. There is a need for enhanced attention and accountability related to health‐related social needs, especially housing, and mental and behavioural health, to end the HIV epidemic.Impact: Globally, we are striving to end the HIV epidemic with evidence‐informed interventions. The nurse‐led hospital‐to‐community and the hospital‐only interventions evaluated here improved HIV outcomes with most gains realized by the nurse‐led transitional care model. Integrating lessons from these programmes, with increased attention and accountability for addressing social needs, can improve practice and policies to achieve programmatic and national goals related to HIV and other diseases, and more critically, to meet the goals of the people we serve.Patient or public contribution: Patients, staff and leadership at the University of Maryland Institute of Human Virology JACQUES Initiative and University of Maryland Medical Center THRIVE clinic contributed to the design and implementation of the programmes and informed the programme evaluation study.